• Novo strikes up personalised diabetes treatment deal with Glooko pharmafile
    January 17, 2017
    Novo Nordisk has entered into a partnership with Californian firm Glooko to develop a number of offerings to aid with a range of issues affecting patients with type 1 and 2 diabetes including treatment adherence and blood glucose management.
PharmaSources Customer Service